<?xml version="1.0" encoding="UTF-8"?>
<ref id="B76-antibiotics-09-00353">
 <label>76.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hatziieremia</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Gray</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ferro</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Paul</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Plevin</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFÎºB signalling pathways in monocytes/macrophages</article-title>
  <source>Br. J. Pharm.</source>
  <year>2006</year>
  <volume>149</volume>
  <fpage>188</fpage>
  <lpage>198</lpage>
  <pub-id pub-id-type="doi">10.1038/sj.bjp.0706856</pub-id>
 </element-citation>
</ref>
